AUGMENTIN 1.2GM INJECTION

Serious side effects are rare, but they can occur. These include severe allergic reactions, liver damage, or a decrease in white blood cell count. 

AUGMENTIN 1.2GM INJECTION is a penicillin-type antibiotic that works by stopping the growth of bacteria, while clavulanic acid extends the spectrum of amoxicillin's antibacterial activity and helps to prevent bacterial resistance. 

If you have had a previous allergic reaction to penicillin, it's essential to inform your healthcare provider before starting treatment with AUGMENTIN 1.2GM INJECTION. Depending on the severity of your allergic reaction, your doctor may recommend an alternative medication. 

If you experience any side effects, contact your healthcare provider immediately. Sometimes, they may advise you to stop taking the medication or switch to a different medication. 

AUGMENTIN 1.2GM INJECTION can be taken during pregnancy or breastfeeding, but it's important to consult with a healthcare provider before taking any medication.

NULL interaction of AUGMENTIN 1.2GM INJECTION with other drungs

Report your doctor if you have or have a history of glandular fever, took treatment for liver or kidney problems, or have less urination. Taking AUGMENTIN 1.2GM INJECTION may worsen your existing condition. So inform if you any to you doctor. Regular kidney, liver, and urine tests will be taken to monitor its function. Notify your doctor if you take or take any other medicine. Underlying kidney conditions, patients should avoid discussion about dose alteration. Inform your doctor if you experience any side effects. Talk to your doctor if you are planning or are already pregnant or breastfeeding. 

AMOXYCILLIN,CLAVULANIC ACID is molecule/combination used for making AUGMENTIN 1.2GM INJECTION.

AUGMENTIN 1.2GM INJECTION is prescribed for Infectious Diseases.

Inj Augmentin is an injectable combination antibiotic containing amoxicillin and clavulanic acid. It is used to treat moderate to severe bacterial infections caused by susceptible organisms, particularly when resistance to amoxicillin alone is likely. Common uses include infections of the lungs and airways (such as pneumonia and severe bronchitis), complicated urinary tract infections, intra‑abdominal infections, skin and soft tissue infections, bone and joint infections, and certain gynecological or postoperative infections. The decision to use the injectable form is made by a doctor based on the severity of the infection and the patient’s ability to take oral medication.

Inj Augmentin contains two active components that work together. Amoxicillin is a penicillin‑class antibiotic that kills bacteria by interfering with the formation of their cell wall, which is essential for bacterial survival. Some bacteria produce enzymes called beta‑lactamases that can break down amoxicillin and make it ineffective. Clavulanic acid inhibits many of these beta‑lactamase enzymes, protecting amoxicillin from inactivation and extending its spectrum of activity. This combination allows Inj Augmentin to treat infections caused by many beta‑lactamase‑producing bacteria that would otherwise be resistant to amoxicillin alone.

Inj Augmentin is given only by healthcare professionals, usually in a hospital or clinical setting. It is administered by intravenous route, either as a slow injection or as an infusion diluted in a suitable fluid over a specified period. The exact method, dose, and frequency are determined by the treating physician based on the type and severity of infection, the patient’s age and body weight, and kidney and liver function. Patients should not attempt to self‑inject this medicine. If outpatient intravenous therapy is arranged, it should still be supervised by trained medical staff.

Common side effects of Inj Augmentin include gastrointestinal symptoms such as diarrhea, loose stools, nausea, vomiting, and abdominal discomfort. Some patients may experience headache, dizziness, or mild skin rash. Local reactions at the injection site, such as pain, redness, or inflammation, can also occur. These effects are often mild and temporary, but persistent or severe symptoms should be reported to the healthcare provider. Because this medicine can disturb normal gut bacteria, there is a risk of antibiotic‑associated colitis, including Clostridioides difficile‑associated diarrhea, particularly with prolonged use.

Yes, Inj Augmentin can cause allergic reactions, especially in individuals who are allergic to penicillins, cephalosporins, or other beta‑lactam antibiotics. Reactions may range from mild skin rash and itching to severe, potentially life‑threatening anaphylaxis. Signs of a serious allergic reaction include sudden rash, hives, swelling of the face, lips, tongue, or throat, difficulty breathing, wheezing, or a sudden drop in blood pressure. These require immediate medical attention. Patients should always inform their doctor about any previous allergic reactions to antibiotics before receiving Inj Augmentin.

Inj Augmentin can be used in patients with kidney impairment, but dose adjustment or extension of the dosing interval is often required because amoxicillin and its metabolites are primarily eliminated by the kidneys. In patients with significantly reduced kidney function, accumulation of the drug can increase the risk of side effects, including seizures in predisposed individuals. The treating physician will assess kidney function, usually by estimating creatinine clearance or glomerular filtration rate, and will modify the dosing regimen accordingly. Such patients should be monitored closely during therapy.

Inj Augmentin has been associated with liver‑related side effects in some patients. These may include elevations in liver enzymes, cholestatic jaundice, or hepatitis. Such reactions are generally reversible after discontinuation but can occasionally be serious. The risk appears higher in older adults, males, and with prolonged or repeated courses. Patients with pre‑existing liver disease should use this medicine with caution, and liver function tests may be monitored during treatment. Symptoms such as persistent nausea, vomiting, dark urine, pale stools, severe fatigue, or yellowing of the skin or eyes should be reported immediately.

Amoxicillin–clavulanic acid has been used during pregnancy when clearly needed, and available human data do not suggest a major increase in the risk of congenital malformations. However, as with all medicines, Inj Augmentin should be used during pregnancy only if the potential benefit justifies any potential risk to the mother and fetus. The decision is made by the treating physician after assessing the severity of the infection and alternative options. Pregnant patients should not start or stop this medicine on their own and should inform their doctor if they are pregnant or planning pregnancy.

Both amoxicillin and clavulanic acid pass into breast milk in small amounts. They are generally considered compatible with breastfeeding, but the infant should be observed for possible effects such as diarrhea, candidiasis (oral thrush or diaper rash), or rash. In most cases, breastfeeding can continue while the mother receives this antibiotic, provided the infant is monitored and the treatment is clinically necessary. The prescribing doctor will weigh the benefits of treatment for the mother against any potential risks to the breastfed child and may adjust therapy if concerning symptoms appear in the infant.

Before and during treatment with Inj Augmentin, inform your healthcare provider about any history of allergy to penicillins, cephalosporins, or other medicines; any liver or kidney disease; and all other medications or supplements you are taking. Do not use this medicine for viral infections such as colds or flu. Report any severe or persistent diarrhea, especially if it is watery or contains blood, as this may indicate antibiotic‑associated colitis. Inform your doctor if you develop skin rash, itching, breathing difficulty, yellowing of the eyes or skin, dark urine, or unusual bruising or bleeding. Complete the full prescribed course unless your doctor advises otherwise.

Yes, Inj Augmentin can interact with certain medicines. For example, it may affect the action of oral anticoagulants such as warfarin, potentially altering blood clotting parameters and increasing bleeding risk, so closer monitoring of coagulation tests may be required. Concomitant use with certain drugs that affect kidney function or are eliminated by the kidneys may influence blood levels of one or both agents. Allopurinol taken with amoxicillin has been associated with an increased risk of skin rash. High‑dose or prolonged use with other antibiotics can alter gut flora more extensively. Always inform your doctor about all prescription medicines, over‑the‑counter products, and herbal supplements you are using so that potential interactions can be assessed and monitored.